EX-10.1
from 10-Q
11 pages
Employment Agreement This Employment Agreement (This “Agreement”) Is Made and Entered Into as of August 10, 2022 by and Between Neogenomics, Inc. (The “Company”) and Alicia Olivo (The “Executive”). Whereas, the Executive and the Company Entered Into a Certain Letter Agreement Dated May 11, 2022 (The “Previous Letter Agreement”) Memorializing the Terms and Conditions of the Executive’s Role as Interim General Counsel of the Company, Effective as of April 25, 2022; Whereas, the Executive Possesses Certain Experience and Expertise That Qualifies Him or Her to Provide the Direction and Leadership Required by the Company; And
12/34/56
EX-10.1
from 8-K
16 pages
As We Have Discussed, Your Employment With Neogenomics, Inc. (The “Company”) Is Coming to an End as a Result of Your Retirement, Effective as of April 1, 2025 (The “Retirement Date”). the Purpose of This Letter Agreement (This “Agreement”) Is to Confirm the Terms Concerning Your Transition From Employment. Capitalized Terms Not Defined in This Agreement Will Have the Respective Meanings Ascribed to Them in the Employment Agreement by and Between You and the Company, Dated and Amended as of August 15, 2022 (The “Employment Agreement”)
12/34/56
EX-10.23
from 10-K
7 pages
As We Have Discussed, Your Employment With Neogenomics, Inc. (The “Company”) Is Coming to an End, Effective as of December 31, 2022, (The “Separation Date”). the Purpose of This Letter Agreement (This “Agreement”) Is to Confirm the Terms Concerning Your Transition From Employment. Capitalized Terms Not Defined in This Agreement Will Have the Respective Meanings Ascribed to Them in the Employment Agreement by and Between You and the Company, Dated as of February 22, 2022 (The “Employment Agreement”)
12/34/56
